Clinical trial
Massive Transfusion in Children: a Platform RCT of Whole Blood Compared to Component Therapy and Tranexamic Acid to Placebo in Life-threatening Traumatic Bleeding
NCT06070350 is registered in ClinicalTrials.gov with Philip Spinella as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Massive Transfusion in Children: a Platform RCT of Whole Blood Compared to Component Therapy and Tranexamic Acid to Placebo in Life-threatening Traumatic Bleeding
- Lead sponsor
- Philip Spinella
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- November 1, 2024
- Completion date
- October 1, 2028
- Enrollment
- 1,000 (estimated)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
hemorrhagic shock, trauma injury